Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06495619

Integrative Intervention Strategies for Binge Eating in Patients With Overweight or Obesity

Effectiveness of Integrative Intervention Strategies for Binge Eating in Patients With Overweight or Obesity: A Multidisciplinary Approach

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
G. d'Annunzio University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The main goal of the clinical trial is to compare the short- and long-term outcomes of three 12-week interventions among outpatients with overweight/obesity and binge eating (BE): 1. treatment-as-usual for weight loss (TAU); 2. combined TAU and guided self-help for improving eating behaviors (TAU+GSH); 3. combined TAU, GSH, and biofeedback (TAU+GSH+BF). The primary outcomes will be self-reported reduction of days with objective BE episodes (OBEs). The secondary outcomes will be impulsivity, emotion dysregulation, interoceptive awareness, distress, physiological correlates of arousal (skin conductance and heart rate variability), and inflammatory biomarkers. The TAU+GSH arm is expected to be comparable to the TAU+GSH+BF arm in reducing the number of days with OBEs but is expected to be significantly less effective in improving secondary outcomes (impulsivity, emotional dysregulation, interoceptive awareness, distress, physiological inflammatory markers). The TAU arm is expected to show significant inferiority regarding the primary and secondary outcomes and cost-effectiveness compared to the TAU+GSH and TAU+GSH+BF conditions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALtreatment-as-usuallife style modification intervention for weight loss
BEHAVIORALcombined TAU and guided self-helpcombined TAU and guided self-help for improving eating behaviors
BEHAVIORALcombined TAU, GSH, and biofeedbackcombined TAU, GSH, and biofeedback for improving eating behaviors and interoceptive awareness and arousal regulation

Timeline

Start date
2024-08-01
Primary completion
2024-12-01
Completion
2025-06-30
First posted
2024-07-11
Last updated
2024-07-11

Source: ClinicalTrials.gov record NCT06495619. Inclusion in this directory is not an endorsement.